Chemomab Therapeutics Ltd. (CMMB)
NASDAQ: CMMB · Real-Time Price · USD
1.040
-0.050 (-4.59%)
Apr 1, 2025, 4:00 PM EDT - Market closed

Chemomab Therapeutics Statistics

Total Valuation

CMMB has a market cap or net worth of $19.61 million. The enterprise value is $6.05 million.

Market Cap 19.61M
Enterprise Value 6.05M

Important Dates

The last earnings date was Monday, March 3, 2025, before market open.

Earnings Date Mar 3, 2025
Ex-Dividend Date n/a

Share Statistics

CMMB has 18.86 million shares outstanding. The number of shares has increased by 38.15% in one year.

Current Share Class n/a
Shares Outstanding 18.86M
Shares Change (YoY) +38.15%
Shares Change (QoQ) +7.55%
Owned by Insiders (%) 15.80%
Owned by Institutions (%) 6.50%
Float 11.82M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 1.52
P/TBV Ratio 1.48
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.98, with a Debt / Equity ratio of 0.02.

Current Ratio 4.98
Quick Ratio 4.96
Debt / Equity 0.02
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -91.34% and return on invested capital (ROIC) is -58.96%.

Return on Equity (ROE) -91.34%
Return on Assets (ROA) -47.10%
Return on Invested Capital (ROIC) -58.96%
Return on Capital Employed (ROCE) -107.22%
Revenue Per Employee n/a
Profits Per Employee -$697,250
Employee Count 20
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +33.50% in the last 52 weeks. The beta is 0.49, so CMMB's price volatility has been lower than the market average.

Beta (5Y) 0.49
52-Week Price Change +33.50%
50-Day Moving Average 1.66
200-Day Moving Average 1.54
Relative Strength Index (RSI) 29.32
Average Volume (20 Days) 153,872

Short Selling Information

Short Interest 269,535
Short Previous Month 389,864
Short % of Shares Out 1.44%
Short % of Float n/a
Short Ratio (days to cover) 0.31

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -14.74M
Pretax Income -19.36M
Net Income -13.95M
EBITDA -14.67M
EBIT -14.74M
Earnings Per Share (EPS) -$0.86
Full Income Statement

Balance Sheet

The company has $14.27 million in cash and $324,000 in debt, giving a net cash position of $13.94 million or $0.74 per share.

Cash & Cash Equivalents 14.27M
Total Debt 324,000
Net Cash 13.94M
Net Cash Per Share $0.74
Equity (Book Value) 13.54M
Book Value Per Share 0.72
Working Capital 12.82M
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

CMMB does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -38.15%
Shareholder Yield -38.15%
Earnings Yield -69.77%
FCF Yield n/a

Analyst Forecast

The average price target for CMMB is $9.00, which is 765.39% higher than the current price. The consensus rating is "Strong Buy".

Price Target $9.00
Price Target Difference 765.39%
Analyst Consensus Strong Buy
Analyst Count 2
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) -58.80%
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1